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Introduction {#sec1}
============

The p53 family of proteins, p53, p63, and p73, are sequence-specific transcription factors that are required for cell cycle control, DNA repair, apoptosis, adhesion, organ development, and cell differentiation ([@bib30], [@bib49], [@bib63], [@bib42], [@bib59], [@bib21]). All three p53 family members share a high degree of structural and amino acid sequence similarities within their transactivation domains, DNA binding domains, and oligomerization domains ([@bib19], [@bib11]), which accounts for similar genomic binding sites and regulation of overlapping target genes. Unlike p53, p63 and p73 are transcribed from two separate promoters that encode functionally divergent variants. The transcriptionally active (TA) isoform encodes the full-length protein, whereas the alternative transcript (ΔN) encodes an isoform lacking the amino-terminal transactivation domain ([@bib30], [@bib63]). Thus, ΔNp63 and ΔNp73 isoforms act as dominant-negative regulators of TAp63 and TAp73 ([@bib63], [@bib53], [@bib17]).

p63 and p73 play important roles in cell differentiation and tissue development. p63 is a key regulator of ectodermal differentiation and stratification of the epidermis. Mice lacking p63 fail to develop stratified epithelia, exhibit defective limb and glandular epithelial development, and die shortly after birth due to dehydration ([@bib40], [@bib64]). Mice deficient for all isoforms of p73 exhibit runting, sterility, hippocampal dysgenesis and hydrocephalus, as well as chronic infection and inflammation in the lungs, sinus, and ears ([@bib65]). The development of p73-isoform-specific knockout mouse models provided significant insight into the roles of select p73 isoforms. TAp73-deficient mice exhibit sterility, hippocampal dysgenesis, hydrocephalus, premature aging, genomic instability, and increased frequency of tumors ([@bib58]). In contrast, mice that lack ΔNp73 are fertile and display signs of neurodegeneration, including hippocampal dysgenesis and hydrocephalus ([@bib61]). Thus the sterility defects observed in the global p73-deficient animals are due to a deficiency in the TAp73 isoform. Recently, our laboratory ([@bib37]) and others ([@bib41]) discovered that TAp73 is required for multiciliated cell differentiation and acts as a transcriptional regulator of a gene network required for ciliogenesis. The discovery provided mechanistic insight into the diverse phenotypes observed in p73-deficient mouse models. Impaired cilia formation in p73-deficient mice leads to insufficient clearance of pathogens from the lungs and sinuses causing chronic inflammation. Furthermore, loss of cilia in reproductive tissues decreases transport of the sperm and ova through epididymis and fallopian tubes, respectively, leading to infertility.

Other phenotypes of p73-deficient mice have been reported that are likely to originate from processes unrelated to ciliogenesis. Male mice that lack TAp73 exhibit increased DNA damage and apoptosis in spermatogonial cells within the testes, which results in defective germ cell maturation and differentiation, required for proper spermatogenesis ([@bib24], [@bib21]). TAp73-deficient female mice exhibit meiotic spindle formation abnormalities during oocyte maturation and impaired ovulation ([@bib58]). We report herein that p73 expression in the ovarian follicle, the structure in which the oocyte develops, is critical for oocyte development, ovulation, and fertility. Specifically, p73 is required in granulosa cells for the expression of a p73-dependent gene set that regulates cell adhesion and migration, including genes that encode key components of granulosa-cell-associated focimatrix.

Results {#sec2}
=======

p73 Is Required for Murine Ovarian Follicle Maturation {#sec2.1}
------------------------------------------------------

We analyzed ovaries from age-matched nulliparous female mice genetically engineered to lack functional p73 in all tissues (referred to as p73−/− hereafter and described in \[[@bib37]\]). Histological analysis of ovaries in 12-week-old p73+/+ female mice confirmed the presence of corpus luteum, the final stage of the mature ovarian follicle, suggesting that follicle maturation and ovulation were ongoing in mice at this age. p73+/+ ovaries harbored an average of 12 luteal structures per ovary, whereas age-matched p73−/− ovaries had an average of 1 luteal structure per ovary (p value \<0.01) ([Figures 1](#fig1){ref-type="fig"}A and 1B). We quantified the total number of follicles per ovary at various stages of development (primordial, primary, secondary, and antral stages) using methodology as previously described ([@bib31]) ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). We observed a 35% decrease in the number of primary follicles (p value \<0.001), a 59% decrease in the number of secondary follicles (p value \<0.001), and a 49% decrease in the number of antral follicles (p value \<0.001), but no significant difference in the number of primordial follicles in p73−/− mice compared with p73+/+ littermates ([Figure 1](#fig1){ref-type="fig"}C).Figure 1p73 Is Required for Murine Ovarian Follicle Development(A) Representative H&E images of p73+/+ and p73−/− ovaries (scale bars, 400 μm and 100 μm, respectively). Arrowheads and labels represent corpora lutea (CL) and different stages of follicle development: Prd, primordial; Prm, primary; Sec, secondary; Ant, antral follicles.(B and C) Each data point represents the average of two independent manual quantifications of six ovaries per genotype. Bars represent the mean. (B) Total number of corpus luteum per ovary (C) Total number of follicles per ovary. \*\*p value\< 0.01, \*\*\*p value \< 0.001.(D and E) Representative H&E (asterisks represent granulosa cells and arrowheads represent theca cells) and IF images of p73+/+ and p73−/− ovaries show that (D) p73 (red) co-localizes with granulosa cell marker FOXL2 (green) in the follicles and (E) p73 (red) is not expressed in theca cells, which are stained by CYP17A1 (green) (scale bar, 50 μm).See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Analysis of p73 protein levels in murine ovaries, at 6, 9, 12, and 16 weeks of age, confirmed that full-length p73 protein was expressed in ovaries collected at all time points in p73+/+ animals and was not expressed in p73−/− animals ([Figure S1](#mmc1){ref-type="supplementary-material"}C). To determine the localization of p73 protein within the ovary, we used well-established cell markers to stain follicular granulosa cells (FOXL2) ([@bib50]) and follicular theca cells (CYP17A1) ([@bib43]). Through immunofluorescence (IF) staining, p73 was expressed in FOXL2-positive granulosa cells ([Figure 1](#fig1){ref-type="fig"}D, top panel) but not in CYP17A1-positive theca cells ([Figure 1](#fig1){ref-type="fig"}E, top panel). Although the number of follicles were reduced in the absence of p73, we found that, in cases in which follicles were able to form in p73−/− ovaries, the lack of p73 did not block the formation of the granulosa or theca cell layers in the follicle ([Figures 1](#fig1){ref-type="fig"}D and 1E, lower panels). We further analyzed p73 expression in human ovaries using data obtained from the Genotype-Tissue Expression (GTEx) Project (analysis date: January 19, 2018) and found that p73 is expressed at 0.6 transcripts per million (TPM). Specifically, TAp73α and TAp73β are the predominant N-terminal isoforms expressed in human ovaries ([Figure S1](#mmc1){ref-type="supplementary-material"}D).

Given the potential for hetero-oligomerization between p73 and its family member p63 ([@bib8], [@bib45], [@bib19]), we determined if p63 and p73 were co-expressed during follicular development using dual IF detection of the proteins. p63 expression was restricted to oocytes (arrowhead) of primordial follicles in p73+/+ ([Figure S1](#mmc1){ref-type="supplementary-material"}E, top panel), consistent with previously published data showing that p63 expression in primordial follicles promotes genome integrity during meiotic arrest ([@bib54]). The oocyte-restricted expression pattern of p63 was unaltered in p73−/− ovaries ([Figure S1](#mmc1){ref-type="supplementary-material"}E, lower panel).

The ovarian phenotypes observed in our p73−/− female mice are consistent with the fertility defects reported in TAp73-deficient animals, but not ΔNp73-deficient mice, given that both females and males are fertile in the latter ([@bib58], [@bib61]). TAp73-deficient females showed defective follicle development and significantly decreased ovulation rate relative to wild-type animals in response to exogenous hormone stimulus, and the few ovulated oocytes observed were trapped under the bursa and unable to reach the fallopian tube for implantation ([@bib58]), possibly due to the lack of ciliated cells lining the oviduct ([@bib37]). The corpora lutea are the primary sites of progesterone production after ovulation in mice ([@bib1], [@bib47]). Therefore, the lack of corpora lutea observed in our p73−/− female mice ([Figure 1](#fig1){ref-type="fig"}B) led us to compare the levels of circulating hormones in the p73+/+ and p73−/− female mice.

Loss of p73 Leads to a Significant Decrease in Circulating Progesterone {#sec2.2}
-----------------------------------------------------------------------

Given the impact of p73 loss on folliculogenesis and the number of corpora lutea, we measured circulating progesterone in nulliparous p73+/+ and p73−/− mice at 6, 9, and 12 weeks of age. Progesterone levels fluctuate throughout the stages of the estrous cycle ([@bib7]). We assessed the estrous cycle through vaginal cytology and observed that p73−/− mice exhibit aberrant estrous cycle with prolonged diestrus stage compared with p73+/+ ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Given the acyclic nature of p73−/− female mice, all circulating hormones were analyzed from the only shared stage (diestrus) between both phenotypes. Progesterone levels decreased nearly 75% in p73−/− samples collected at 6 weeks of age (p value \< 0.05) and 82% (p value \< 0.01) at 12 weeks of age relative to p73+/+ mice ([Figure 2](#fig2){ref-type="fig"}A). Circulating estradiol levels in p73−/− mice were similar to those in p73+/+ mice at each time point analyzed ([Figure 2](#fig2){ref-type="fig"}B), although testosterone was reduced 55% in p73−/− samples harvested at 12 weeks of age (p value \<0.01) ([Figure 2](#fig2){ref-type="fig"}C).Figure 2Analysis of Circulating Progesterone in p73+/+ and p73−/− Female MicePlasma levels measure by ELISA of (A) progesterone, (B) estradiol, and (C) testosterone from five female mice per genotype at 6, 9, and 12 weeks of age; assay sensitivity range 0.2--50 ng/mL, 1--100 pg/mL, and 5--100 pg/mL, respectively. Bars represent the mean. \*p value \< 0.05, \*\*p value \< 0.01.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Circulating hormones originating from the pituitary gland, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), and growth hormone (GH), are key regulators of the estrous cycle and thus could exert a marked influence in ovarian progesterone production. Therefore, we measured circulating FSH levels in 12-week-old nulliparous mice, finding a 50% decrease in FSH levels in p73−/− compared with age-matched p73+/+ mice (p value \<0.01) ([Figure S2](#mmc1){ref-type="supplementary-material"}B). These findings are consistent with previous studies showing that FSH promotes granulosa-theca cell interactions that drive the production of ovarian testosterone ([@bib52]), thus constituting a possible mechanism to explain the decrease in testosterone observed in p73−/− female mice. LH levels were modestly decreased in p73−/− mice, albeit not to a statistically significant degree ([Figure S2](#mmc1){ref-type="supplementary-material"}C), and no difference in circulating GH was observed between p73+/+ and p73−/− samples ([Figure S2](#mmc1){ref-type="supplementary-material"}D).

To determine if the hormonal differences in the p73−/− mice were linked to gross abnormalities in pituitary gland morphology due to hippocampal dysgenesis and hydrocephalus ([@bib65], [@bib55]), we analyzed pituitary gland tissue sections from p73+/+ and p73−/− female mice. The murine pituitary gland is composed of anterior (pars distalis, D; and intermedia, I) and posterior (pars nervosa, N) lobes. Despite diminished FSH production in p73−/− mice, we did not observe any overt histological differences in the pars distalis (asterisk) ([Figure S2](#mmc1){ref-type="supplementary-material"}E), where gonadotropin hormones (FSH, LH, and GH) are produced and secreted. In addition, we evaluated p73 expression in the pituitary gland of p73+/+ mice through IF. We observed p73-positive cells in pars intermedia (solid-line box), but not in pars distalis (dashed-line box) ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Previous studies have shown that TAp73-deficient male mice have normal levels of FSH, LH, and gonadotropin-releasing hormone ([@bib21]). In addition, immature TAp73-deficient ovaries fail to respond to exogenous hormone stimulation and show a significantly decreased ovulation rate compared with age-matched wild-type mice ([@bib58]), further supporting normal pituitary gland signaling. Granulosa cells in growing follicles produce activin and inhibin as a feedback mechanism to regulate FSH secretion ([@bib32]). Thus it is possible that the loss of p73 in granulosa cells, and the decreased number of growing follicles observed in p73−/− females, may negatively interfere with ovarian-pituitary feedback signaling required for proper FSH secretion.

Ectopic Progesterone Partially Rescues Ovarian Follicle Development in p73-Deficient Mice {#sec2.3}
-----------------------------------------------------------------------------------------

To determine if ectopic progesterone could rescue ovarian follicle maturation, 60-day-release progesterone pellets (15 mg) were implanted subcutaneously in 5-week-old nulliparous p73+/+ and p73−/− female mice and ovaries were analyzed 21 days after implantation. The ovaries from p73−/− mice with the placebo pellet harbored fewer primary, secondary, and antral follicles and were substantially smaller than placebo-treated p73+/+ mice ([Figures 3](#fig3){ref-type="fig"}A and 3B). However, ovaries from p73−/− mice treated with ectopic progesterone were similar in size to ovaries from placebo- or progesterone-treated p73+/+ mice ([Figure 3](#fig3){ref-type="fig"}A) and contained a greater number of primary, secondary, and antral follicles than placebo-treated p73−/− ovaries, similar to what was seen in progesterone- or placebo-treated p73+/+ mice ([Figure 3](#fig3){ref-type="fig"}C). As a control, circulating progesterone was measured at the time when the mice were killed to confirm that ectopic progesterone pellet increased circulating progesterone in p73−/− mice to levels comparable with both placebo- and progesterone-treated p73+/+ mice ([Figure 3](#fig3){ref-type="fig"}D).Figure 3Progesterone Rescues Follicle Development in *p73*-Deficient OvariesProgesterone slow-release pellet or placebo control (15 mg/pellet, 60-day extended release) were implanted in five female mice per genotype at 5 weeks of age.(A) Representative H&E images of placebo control and ectopic progesterone-treated ovaries of p73+/+ and p73−/− mice (scale bar, 200 μm).(B and C) (B) Follicle quantification of placebo control and (C) progesterone-treated p73+/+ and p73−/− ovaries, respectively. Data are shown as number of follicles per ovary; Prd, primordial; Prm, primary; Sec, secondary; Ant, antral.(D) Plasma levels of progesterone were measured through ELISA from placebo control and progesterone-treated p73+/+ and p73−/− female mice. \*p value \< 0.05.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

To assess the effect of ectopic progesterone on female sterility in our mouse model ([@bib37]), we determined the reproductive ability of placebo- or progesterone-treated p73+/+ and p73−/− female mice through mating trials. Twelve-week-old p73+/+ and p73−/− female mice were implanted with placebo or progesterone pellets and housed with p73+/+ males for a period of 14 days. At day 15, pregnancy status was determined and tissue was harvested for histological analysis. In p73+/+, two of two placebo-treated and two of three progesterone-treated female mice became pregnant, indicating that the level of ectopic progesterone administered did not inhibit their reproductive ability. In contrast, none of the five p73−/− mice, either placebo- (two mice) or progesterone-treated (three mice), became pregnant (data not shown). These results were not surprising given the lack of ovulation, corpus luteum formation, and ciliated cells in the p73-deficient mice ([@bib37]). Ciliated cells are required for transport of the oocyte through the oviduct and to the uterus ([@bib9], [@bib18]). Also, we analyzed the ability of ectopic progesterone to rescue corpus luteum formation by implanting placebo or progesterone pellets (5 mg) in 12-week-old nulliparous p73+/+ and p73−/− female mice. After 21 days, corpora lutea (arrowhead) were observed in p73+/+ with placebo or progesterone pellet. However, administration of ectopic progesterone in p73−/− mice was not able to rescue the formation of corpora lutea ([Figure S3](#mmc1){ref-type="supplementary-material"}, arrowhead).

Ectopic Progesterone Rescues Lobulo-Alveolar Budding in p73-Deficient Mice {#sec2.4}
--------------------------------------------------------------------------

Mice that lack progesterone receptor exhibit defects in follicle rupture, causing impaired ovulation, absence of corpora lutea, and female infertility ([@bib36], [@bib35]), similar to the phenotypes observed in our p73−/− female mice. Furthermore, impaired progesterone signaling leads to defects in proper mammary gland development by impeding the formation of lobulo-alveolar buds, small grape-like epithelial protrusions that, in the event of pregnancy, will generate the milk-producing alveoli ([@bib20], [@bib6], [@bib36]). Given the similarities between the progesterone receptor-deficient mice and our p73−/− female mice, we assessed the hormonally responsive function of the mammary glands from mice treated with slow-release progesterone pellets, as described above. Using whole-mount carmine staining to visualize the mammary epithelium, we noted a 50% reduction (p value \<0.01) in lobulo-alveolar budding in placebo-treated p73−/− mice compared with p73+/+ mice ([Figures 4](#fig4){ref-type="fig"}A and 4B). Progesterone-treated p73−/− female mice exhibited a complete rescue of lobular-alveolar budding and comparable mammary gland morphology to progesterone-treated p73+/+ control ([Figure 4](#fig4){ref-type="fig"}A). Ectopic progesterone significantly increased the number of lobulo-alveolar buds in p73−/− mammary gland by 200% (p value \<0.001) compared with the mammary glands of placebo-treated p73−/− mice ([Figure 4](#fig4){ref-type="fig"}B).Figure 4Ectopic Progesterone Rescues Lobulo-Alveolar Budding Defect in *p73*-Deficient Mammary Gland(A) Whole mammary mount stained with carmine alum shows that ectopic progesterone rescues lobular-alveolar budding in p73−/− female mice (scale bar, 200 mm).(B) Lobulo-alveolar budding quantification of placebo control or progesterone from p73+/+ and p73−/−; values shown represent the average number of side branches per primary branch. \*\*p value\< 0.01, \*\*\*p value \< 0.001.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Of note, the average number of lobular-alveolar buds was reduced in p73−/− mice by 45% at 6 weeks (p value \<0.05), 60% at 9 weeks (p value \<0.001), and 66% at 12 weeks (p value \<0.001) of age compared with p73+/+ littermates ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Despite decreased lobulo-alveolar budding, the histological architecture of mammary glands was unaffected by loss of p73 ([Figure S4](#mmc1){ref-type="supplementary-material"}C), with a well-organized luminal cell layer displaying apico-basal polarization (asterisks) and basally oriented myoepithelial cell layer (arrowheads), similar to what was seen in the mammary ductal epithelium of p73+/+ littermates. IF staining in p73+/+ mammary glands revealed nuclear p73 localization in basally located cells that stained positive for the myoepithelial/basal cell marker keratin 14 ([Figure S4](#mmc1){ref-type="supplementary-material"}C). As expected, we did not observe p73 expression in p73−/− mammary glands ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Similar to our analyses in the ovaries, IF staining of p73+/+ mammary glands with antibodies against p63 confirmed myoepithelial/basal localization of p63 and p73 ([Figure S4](#mmc1){ref-type="supplementary-material"}D) ([@bib64], [@bib5]). Interestingly, p63 co-localized with a subset of p73-expressing cells in the myoepithelial layer suggesting that these two proteins interact in specific myoepithelial cells of the mammary gland. Furthermore, we found that p63 expression was retained in the myoepithelial layer of p73−/− mammary glands, suggesting that decreased lobulo-alveolar budding in p73−/− is not due to impaired p63 expression ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

p73 Regulates a Biological Adhesion Gene Network in Murine Granulosa Cells {#sec2.5}
--------------------------------------------------------------------------

To gain mechanistic insight into the defects in follicle development and ovulation in p73−/− ovaries, laser capture microdissection was used to isolate granulosa cells from p73+/+ and p73−/− antral follicles of age-matched nulliparous mice (three mice per genotype). Principal component analysis revealed a clear separation between p73+/+ and p73−/− transcriptional changes in antral follicle samples in principal component 1 ([Figure 5](#fig5){ref-type="fig"}A). Accordingly, we identified 3,209 protein-coding genes differentially expressed between p73+/+ and p73−/− antral follicles ([Table S1](#mmc2){ref-type="supplementary-material"}), of which 1,603 were enriched in p73+/+ antral follicles and 1,606 were enriched in p73−/− antral follicles. Gene Ontology (GO) enrichment (maximum false discovery rate \[FDR \< 2.22 × 10^−16^\]) identified nine GO categories related to biological adhesion, including extracellular matrix organization, positive regulation of cell adhesion, cell-substrate adhesion, positive regulation of locomotion, extracellular structure organization, positive regulation of cellular component movement, and positive regulation of cell motility ([Figure 5](#fig5){ref-type="fig"}B; [Table S2](#mmc3){ref-type="supplementary-material"}). These findings are consistent with previous reports of p73-mediated regulation of cell-cell adhesion and migration through integrin-β4 ([@bib62]), vascular endothelial growth factor , and transforming growth factor β signaling ([@bib14], [@bib38], [@bib3]).Figure 5p73 Regulates a Gene Network Involved in Biological Adhesions in Antral Follicles(A) Principal component analysis (PCA) plot of RNA sequencing (RNA-seq) analysis from LCM-isolated p73+/+ and p73−/− antral follicles (n = 3 mice/genotype).(B) Table shows top nine GO categories enriched in p73+/+ versus p73−/− antral follicles (FDR \< 2.22 × 10^−16^).(C) PCA plot of RNA-seq analysis from p73+/+ and p73−/− MGCs after ectopic p73 or control.(D) Venn diagram showing the overlap between genes expressed in p73+/+ antral follicles (TPM \> 1) and upregulated after ectopic p73 expression in p73+/+ and p73−/− MGCs.(E) Table listing the top 19 GO categories enriched in 1,649 overlapping genes from (D).(F) Heatmap of expression for core 208 p73-upregulated granulosa cell genes. These genes were selected by identifying the 1,649 genes in (D) that were present in three or more of the enriched GO categories from (E) (FDR p value \< 0.1).See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc2){ref-type="supplementary-material"}, [S2](#mmc3){ref-type="supplementary-material"}, [S3](#mmc4){ref-type="supplementary-material"}, [S4](#mmc5){ref-type="supplementary-material"}, [S5](#mmc6){ref-type="supplementary-material"} and [S6](#mmc7){ref-type="supplementary-material"}.

We isolated and cultured primary mouse granulosa cells (MGCs) from p73+/+ mice and transduced the cells with lentivirus expressing TAp73β for 48 hr. We did not observe any difference in cell morphology or the levels of cleaved poly (ADP-ribose) polymerase 1 (PARP1) between control MGCs and those expressing ectopic p73 ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). The rationale for using TAp73β was based on previously published data showing that TAp73β exhibits the highest level of transcriptional activity among p73 isoforms ([@bib60], [@bib33]) as well as the fact that the TAp73β isoform is highly expressed in human ovaries ([Figure S1](#mmc1){ref-type="supplementary-material"}D). We measured global gene expression changes by RNA sequencing after ectopic p73 in MGCs isolated from both p73+/+ and p73−/− female mice and identified clear separation of samples after ectopic p73 ([Figure 5](#fig5){ref-type="fig"}C). Differential expression of 5,178 genes was identified in p73+/+ MGCs after ectopic expression of TAp73β, including 2,896 upregulated genes ([Table S3](#mmc4){ref-type="supplementary-material"}). Similarly, we identified 3,391 differentially expressed genes after TAp73β expression in p73−/− MGCs (2,087 upregulated genes) ([Table S4](#mmc5){ref-type="supplementary-material"}). We identified 1,649 genes commonly upregulated in TAp73β-expressing MGCs and in p73+/+ antral follicles (\>1 TPM) ([Figure 5](#fig5){ref-type="fig"}D, [Table S5](#mmc6){ref-type="supplementary-material"}). GO pathway enrichment analysis identified 19 GO categories (FDR \< 2.22 × 10^−16^), including biological adhesion and migration ([Figure 5](#fig5){ref-type="fig"}E and [Table S6](#mmc7){ref-type="supplementary-material"}). A core set of 208 genes overlapped in at least 3 of the 19 enriched GO categories ([Figures 5](#fig5){ref-type="fig"}F and [S5](#mmc1){ref-type="supplementary-material"}C), including *Adam10*, *Adamts12*, *Icam1*, *Pxn*, and *Mmp14*. Importantly, we identified multiple genes required for the formation of the follicular focimatrix (focal intra-epithelial matrix), which is the extracellular matrix that aggregates between granulosa cells and increases as follicles progress to pre-ovulatory stage ([@bib25], [@bib26], [@bib27]). Key focimatrix genes identified include *Lama1*, *Lama2*, *Lama5*, *Lamb1*, *Hspg2*, *Nid1*, and *Nid2*. These data suggest that p73 is a key regulator of genes involved in cell adhesion and migration.

p73 Regulates Cell Adhesion and Migration {#sec2.6}
-----------------------------------------

We used a well-established *in vitr*o migration assay to analyze the effect of p73 on cell adhesion and migration. To set up the assay, magnetically attachable stencils (MAtS) were placed in culture vessels to create "gaps" in monolayer cell cultures ([@bib2]). The measurement of cell movement into the gaps over time provided a reporter assay for cell adhesion and migration. Due to technical constraints of large-scale MGC isolation and culture, we used mouse embryonic fibroblasts (MEFs) isolated from p73+/+ and p73−/− embryos as well as transformed epithelial cell lines that readily grow in culture. Lentivirally delivered short hairpin RNA sequences against p73 were used to "knockdown" p73 in transformed cell lines (MDA-MB-231 and HCC1806). Cells were plated near confluency surrounding the MAtS and cultured in serum-free media for 14 hr. MAtS were then removed (T = 0 hr) and migration was monitored for 8--11 hr, revealing that loss of p73 significantly decreased cellular migration rate in p73−/− MEFs, MDA-MB-231, and HCC1806 cells when compared with p73+/+ MEFs or vector control ([Figure 6](#fig6){ref-type="fig"}A). Loss of p73 expression was confirmed through qRT-PCR and western blot analysis ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B).Figure 6p73 Regulates Cell Migration(A) MEFs isolated from p73+/+ and p73−/− mice, MDA-MB-231, and HCC1806 cells stably expressing control short hairpin RNA (shRNA) and p73 shRNA were plated in culture dishes containing magnetic stencils and grown to confluency (scale bar, 100 μm). Each dot represents the percentage gap closure per field of view. \*\*\*p value \< 0.001.(B) Table listing adhesion- and migration-associated genes from the core set of 208 genes bound by p73 within 25 kb of their TSS (in HCC1806 cells). For each gene, the q value of the nearby p73 peak and its distance from the TSS of the gene are included.(C) Integrative Genomics Viewer images for selected genes from (B) with tracks for input, p73, and Pol II ChIP-seq in HCC1806 cells. Each sample was normalized to 1X depth of coverage. Individual tracks within a gene are scaled equally. RefSeq gene annotations are in blue schematics at the bottom of each panel on the same scale as the ChIP-seq tracks.See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"} and [Table S7](#mmc8){ref-type="supplementary-material"}.

Given that the most significant difference in cell migration was observed in p73-deficient HCC1806 cells, we performed chromatin immunoprecipitation sequencing (ChIP-seq) on parental HCC1806 cells to determine if p73 directly binds near the transcriptional start site (TSS) of genes involved in cell migration. HCC1806 cells were formaldehyde cross-linked and processed for p73 and RNA polymerase II (Pol II) ChIP-seq, as described in the [Transparent Methods](#mmc1){ref-type="supplementary-material"}. Quality control analysis of these data demonstrated clear separation between ChIP and input signal for p73 and Pol II ([Figure S7](#mmc1){ref-type="supplementary-material"}A). Because the p73 ChIP replicates were highly correlated ([Figure S7](#mmc1){ref-type="supplementary-material"}B), we pooled the samples for peak calling to increase peak detection sensitivity. We identified 3,555 p73 and 19,696 Pol II genomic binding sites ([Table S7](#mmc8){ref-type="supplementary-material"}). Motif analysis showed strong enrichment for the p53 family binding motif ([Figure S7](#mmc1){ref-type="supplementary-material"}C) ([@bib46], [@bib12], [@bib34], [@bib51]). We identified known binding sites in p73 target genes *MDM2* and *CDKN1A* ([Figures S7](#mmc1){ref-type="supplementary-material"}D and S7E) ([@bib4], [@bib29], [@bib13]) ([@bib44], [@bib57]) as well as a binding site in the newly reported p73 target gene *ITGB4* (integrin-β4) ([@bib62]). Since we were comparing murine gene expression data with human ChIP data, we focused our analysis on genes that were increased after p73 expression in MGCS and for which the binding of p73 occurred within 25 kb of the TSS in HCC1806 ChIP. From the 208 p73-regulated core gene set, we found 30 adhesion- and migration-associated genes with a p73 binding site within 25 kb of the TSS of the human gene homolog ([Figure 6](#fig6){ref-type="fig"}B). Of immediate interest were p73 binding sites near genes encoding adhesion *PXN* and focimatrix components *LAMA5*, *NID1*, and *NID2* ([Figure 6](#fig6){ref-type="fig"}C). Paxillin is a scaffolding protein that regulates cytoskeleton remodeling, cell migration, and focal adhesions ([@bib23], [@bib22], [@bib10]).

p73 is necessary for cell migration in transformed epithelial cell line models. Through ChIP-seq, we identified p73 binding within 25 kb of the TSS of genes involved in cell-to-cell adhesion and migration, including *NID1*, *NID2*, *LAMA5*, and *PXN*. Furthermore, ectopic p73 expression is sufficient to upregulate the expression of these genes in MGCs. Collectively, these data support the conclusion that p73 regulates ovarian folliculogenesis and ovulation, in part through regulated expression of adhesion and focimatrix genes necessary for proper follicle maturation.

Discussion {#sec3}
==========

We discovered that p73 is required for proper ovarian follicle development, ovulation, and subsequent corpus luteum formation and progesterone production. Similar to prior findings made with TA-specific p73-deficient male mice ([@bib24]), we observed a significant decrease in levels of circulating progesterone in our p73−/− female mice. Furthermore, we demonstrated that the mammary branching defect observed in p73−/− female mice is secondary to decreased levels of progesterone through a complete rescue of the branching defect after ectopic progesterone administration. Through analysis of gene expression between p73+/+ and p73−/− antral follicles and modulation of p73 expression in various model systems, from primary culture of MGCs to human epithelial cells, we discovered p73-dependent regulation of genes crucial for biological adhesion (*Pxn*) and extracellular matrix interactions required to form proper focimatrix (*Lama5*, *Nid1/2*, and *Hspg2*). Focimatrix levels have been previously linked with steroidogenesis and CYP11A1 ([@bib26], [@bib39]) during ovarian follicle development. Consistent with defective focimatrix formation in our p73-deficient ovarian follicles, we observed a significant decrease in expression of *Cyp11a1*, as well as other hormonally regulated genes including prolactin receptor (*Prlr*), luteinizing hormone/choriogonadotropin receptor (*Lhcgr*), oxytocin receptor (*Oxtr*), steroidogenic factor 1 (*Nr5a1*), and activin B receptor (*Acvr1c*) in p73−/− antral follicles ([Table S1](#mmc2){ref-type="supplementary-material"}). NR5A1 is a transcriptional activator required for the formation of steroidogenic tissues, and cell-specific knockout experiments have shown that *Nr5a1* is necessary for male and female fertility ([@bib15], [@bib28]). Mice that lack ACVR1C expression in granulosa cells exhibit striking similarities to our p73−/− mice including defective follicle development, absence of corpora lutea, and decreased levels of circulating FSH ([@bib48]), providing a possible mechanism for the decreased FSH levels in our p73−/− females. Future studies are needed to determine the direct or indirect mechanism by which p73 regulates the expression of genes required for proper steroidogenesis and hormone signaling in antral follicles.

The lack of functional p73 protein in murine ovaries results in an absence of corpora lutea and an increase in the number of primordial follicles, suggesting a defect in primordial-to-primary follicle transition. We also observed a decrease in FSH levels, which supports the reduced number of developing follicles in p73−/− mice. FSH, secreted from the pituitary gland, is positively and negatively regulated by activin and inhibin, respectively, which are secreted from granulosa cells ([@bib32]). From our analysis, p73 is expressed in the pars intermedia, and not in pars distalis where FSH, LH, and GH are produced. Previous studies have demonstrated that p73-deficient mice exhibit hippocampal dysgenesis and hydrocephalus ([@bib65], [@bib55], [@bib37]). In our p73−/− mice, we also observed hippocampal dysgenesis and hydrocephalus to varying degrees and on a mouse-to-mouse basis across our cohort of p73-deficient mice; we are not able to rule out the possible effect of these phenotypes on pituitary gland function. Future experiments are needed to determine the impact of hippocampal dysgenesis and hydrocephalus on pituitary gland signaling and hormone secretion.

p73 is necessary for multiciliated cell development ([@bib37], [@bib41]), and we observed expression of p73 in ciliated cells that line the oviductal epithelium in mice ([@bib37]). A major role of these ciliated cells is to transport the oocyte to the uterus for implantation ([@bib9], [@bib18]). Mouse models that lack ciliated cells, such as gene knockouts of *Foxj1* ([@bib16]) and *Gemc1* ([@bib56]), have similar phenotypes to our p73-deficient mice ([@bib37]), including female and male infertility. *Gemc1*−/− ovaries exhibit a follicle development defect similar to our p73−/− female mice ([@bib56]). We are not able to rule out a possible paracrine mechanism between the ciliated cells in the oviduct and the granulosa cells in the ovaries. It would be of interest to determine if ciliated cells have additional roles in fertility besides transport of the oocyte, in terms of a direct effect on ovarian follicle development and ovulation through cell-to-cell signaling mechanisms. We posit that p73 is required in both granulosa cells within the follicle and ciliated cells in the oviduct to promote proper follicle development, ovulation, and oocyte implantation.

In summary, we discovered that p73 is required for ovarian follicle development, ovulation, and subsequent corpus luteum formation. The mammary gland branching defect observed in our p73−/− female mice was due to decreased circulating levels of progesterone. We identified a p73-regulated core gene set involved in biological adhesion and cell migration in MGCs. Furthermore, we demonstrated that p73 is necessary for proper epithelial cell migration and identified p73 binding near the TSS of focimatrix component genes and crucial regulators of cell adhesion and migration like *PXN*. We conclude that p73 acts as critical regulator of cell-to-cell adhesion, extracellular matrix interactions, and cell migration and promotes proper follicle development, ovulation, and fertility.

Limitations of the Study {#sec3.1}
------------------------

A limitation of the study was our inability to isolate and culture sufficient numbers of the murine granulosa cells required for cell migration and ChIP experiments, due to technical constraints associated with purification of cells from murine ovaries. To address this limitation, we used another tissue for generation of primary cultures of murine cells from p73+/+ and p73−/− mice as well as the established HCC1806 cell line to analyze the role of p73 in cell migration. For continuity, we used HCC1806 cell line to identify genes involved in migration, to which p73 directly binds through ChIP-seq.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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